Home

SAYPHA VOLUME (1x1ml) / EX PRINCESS VOLUME (1x1ml) CROMA

New

NEW BOX.

VOLUMISING. SAYPHA  Volume is indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume.

Deep and volumetric treatments.

Cross-linked Hyaluronic acid 2.3 % (23 mg/mL).

More details

57,50 €

Volume discounts

Quantity Discount You Save
10 4,00 € Up to 40,00 €

More info

SAYPHA VOLUME (1x1ml) / EX PRINCESS VOLUME (1x1ml) CROMA

IN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA

Saypha

PS single Injectables Volume 422x523

DESCRIPTION

A highly cross-linked, sterile,viscoelastic, biodegradable, monophasic hyaluronic acid gel filler which is best used to correct deep wrinkles, folds and scarring, for facial contouring and building volume.

Injected in the deep dermis with a 27G needle, it is available with or without the addition of lidocaine for additional comfort during treatment.

A clear, colourless, isotonic and homogenized injectable gel implant.

It consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer.

CE Marked Medical Device class III. SMART - a unique method of cross–linking created by CROMA.

INDICATION

VOLUMISING.

SAYPHA Volume is indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume.

Deep and volumetric treatments. 

COMPOSITION

Cross-linked HA 2.3 % (23 mg/mL)

Level of cross-linking 3/4

BDDE (14%)

OPTIMAL SKIN-TOLERANCE by use of non-animal hyaluronic acid.

PACKAGE

NEEDLES 27 G1/2
Box of 1 mL prefilled syringe

Injected in the deep dermis with a 27G needle, it is available with or without the addition of lidocaine for additional comfort during treatment.

Concentration HA

2.3 % (23 mg/mL)

Agente de reticulación

BDDE

Other ingredients 

Phosphate-buffer, NaCI

Dynamic viscosity (at shear rate 2 s-1) 

90.000 – 135.000 mPa.s

Needle

2 x 27G 1⁄2 thin-wall needles 

Packaging

Box of 1 mL syringe

Injection area

Deep dermis or subcutis

Indication

Viscoelastic solution for the correction of deep wrinkles and folds, to increase or restore facial volume, and to shape the facial contours.

Estimated duration in the skin

at least 9 months

INJECTION AREA

Volume of cheekbones

Nasolabial fold

Wrinkles of the puppet

Chin

Facial depressive

TREATMENT SATISFACTION nearly 98% patients are satisfied with our products.

IMMEDIATELY VISIBLE 
effectively after your treatment you see the result.
PAINLESS TREATMENT 
by new combination of Hyaluronic acid and lidocaine
LONG-LASTING RESULTS 
by formulation which shows an effect of severeal months 
Manufactured by Croma-Pharma using their ground-breaking system called SMART (Supreme Monophasic and Reticular Technology).
This manufacturing process is said to increase the life span of the dermal filler, when it is injected under the skin, by optimising the cross-linking and reticulation (inter-locking) of the HA molecular chains.

ABOUT SAYPHA

Croma's range of hyaluronic acid fillers includes six products:

SAYPHA® RICH, SAYPHA® FILLER (with / without lidocaine), SAYPHA® VOLUME (with / without lidocaine) and SAYPHA® VOLUME PLUS Lidocaine.

These products target the individual needs of patients:

SAYPHA® RICH (EC 0459)

Regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines. The product is injected into the superficial dermal layer.

SAYPHA® FILLER (CE 0459) and SAYPHA® FILLER Lidocaine (CE 0120)

Corrects moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA® FILLER Lidocaine). The product is injected into the intermediate to deep dermis.

SAYPHA® VOLUME (CE 0459) and SAYPHA® VOLUME Lidocaine (EC 0120)

Have been developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours. The product is injected into the deeper skin layer (deep dermis or hypodermis).

SAYPHA® VOLUME PLUS Lidocaine (EC 0120)

Is used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy. The product is injected subcutaneously, locally or in the deep dermis. All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.

About Croma-Pharma GmbH

Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. Croma currently manages 12 international sales companies and distributes its products in more than 70 countries.

In its global sales network, Croma focuses on its own brand products for minimally invasive cosmetic medicine.

In addition to a wide range of hyaluronic acid-based fillers from its own production site, Croma markets PDO tensor yarns, a Platelet Rich Plasma System (PRP) and customized skin care technology. within its core strategic markets.

Accessories

Customers who bought this product also bought: